Generics
EQT agrees to acquire majority stake in Adalvo
18 July 2025 - Swedish global investment organisation EQT AB (STO: EQT) announced on Friday that it has agreed with Icelandic private equity company Aztiq to acquire a majority stake in Adalvo, a glob...
Mallinckrodt receives Irish High Court ruling to combine with Endo Inc
18 July 2025 - Specialty pharmaceutical company Mallinckrodt plc announced on Thursday that the Irish High Court has given the necessary ruling to enable its combination with Endo Inc (OTCQX:NDOI), ad...
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
26 June 2025 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Wednesday that it has added Dehydrated Alcohol Injection to its line of cardiovascular drugs.Accord's...
CivicaScript introduces low-cost multiple sclerosis treatment
25 June 2025 - CivicaScript LLC, a Utah-based nonprofit company involved in bringing low-cost generic medicines to US patients, announced on Tuesday the availability of dimethyl fumarate delayed-relea...
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
25 June 2025 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes and sells generic medicines in the United States, announced on Tuesday tha...
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
17 June 2025 - Glenmark Therapeutics Inc USA announced on Monday the launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), a generic version of Pataday Once Daily Relief.The antihis...